Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
REHOVOT, Israel & CAMBÉ, Brazil, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets...
-
REHOVOT, Israel, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today that a...
-
REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) -- AgPlenus, a fully owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), an innovative company aiming to discover, develop and bring to the market...
-
Evogene’s activities relating to design and development of effective and safe next generation agro-chemical products transferred to new subsidiary REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) --...
-
REHOVOT, Israel, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Conference call and webcast, today at 9:00 am Eastern Time Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel...
-
This addition to Biomica’s scientific expertise will support the company’s upcoming steps towards its clinical development REHOVOT, Israel, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Biomica, a subsidiary...
-
Mechanical harvesting is a major bottleneck in conversion of castor bean to a fully modernized commercial crop; Combination of Fantini s.r.l Harvester with Evofuel proprietary varieties has...
-
REHOVOT, Israel, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will...
-
REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today a...
-
REHOVOT, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today its...